Abstract:Abstract Background Severe asthma is a chronic disease contributing to disproportionate disease morbidity and mortality. From the year of 2007, many genome-wide association studies (GWAS) have documented a large number of asthma-associated genetic variants and related genes. Nevertheless, the molecular mechanism of these identified variants involved in asthma or severe asthma risk remains largely unknown. Methods In the current study, we systematically integrated 3 independent expression quantitative trait loci (eQTL) data ( N = 1977) and a large-scale GWAS summary data of moderate-to-severe asthma ( N = 30,810) by using the Sherlock Bayesian analysis to identify whether expression-related variants contribute risk to severe asthma. Furthermore, we performed various bioinformatics analyses, including pathway enrichment analysis, PPI network enrichment analysis, in silico permutation analysis, DEG analysis and co-expression analysis, to prioritize important genes associated with severe asthma. Results In the discovery stage, we identified 1129 significant genes associated with moderate-to-severe asthma by using the Sherlock Bayesian analysis. Two hundred twenty-eight genes were prominently replicated by using MAGMA gene-based analysis. These 228 replicated genes were enriched in 17 biological pathways including antigen processing and presentation (Corrected P = 4.30 × 10 − 6 ), type I diabetes mellitus (Corrected P = 7.09 × 10 − 5 ), and asthma (Corrected P = 1.72 × 10 − 3 ). With the use of a series of bioinformatics analyses, we highlighted 11 important genes such as GNGT2 , TLR6 , and TTC19 as authentic risk genes associated with moderate-to-severe/severe asthma. With respect to GNGT2 , there were 3 eSNPs of rs17637472 (P eQTL = 2.98 × 10 − 8 and P GWAS = 3.40 × 10 − 8 ), rs11265180 (P eQTL = 6.0 × 10 − 6 and P GWAS = 1.99 × 10 − 3 ), and rs1867087 (P eQTL = 1.0 × 10 − 4 and P GWAS = 1.84 × 10 − 5 ) identified. In addition, GNGT2 is significantly expressed in severe asthma compared with mild-moderate asthma ( P = 0.045), and Gngt2 shows significantly distinct expression patterns between vehicle and various glucocorticoids (Anova P = 1.55 × 10 − 6 ). Conclusions Our current study provides multiple lines of evidence to support that these 11 identified genes as important candidates implicated in the pathogenesis of severe asthma.

Genomic Predictors of Asthma Phenotypes and Treatment Response

Pharmacodynamic genome-wide association study identifies new responsive loci for glucocorticoid intervention in asthma

SNPs Identified by GWAS Affect Asthma Risk Through DNA Methylation and Expression of Cis-Genes in Nasal (airway) Epithelium

A Strategy for High-Dimensional Multivariable Analysis Classifies Childhood Asthma Phenotypes from Genetic, Immunological, and Environmental Factors

A genome-wide association study of asthma hospitalizations in adults

Pharmacogenetics of Asthma Therapy

Pharmacogenetic and pharmacogenomic considerations of asthma treatment

Asthma pharmacogenetics and the development of genetic profiles for personalized medicine

Pharmacogenetic Factors Affecting Asthma Treatment Response. Potential Implications for Drug Therapy

Epigenomic partitioning of a polygenic risk score for asthma reveals distinct genetically driven disease pathways

Trends in pharmacogenomics of drugs used in the treatment of asthma

Pharmacogenomics of pediatric asthma

Asthma in Farm Children is More Determined by Genetic Polymorphisms and in Non‐farm Children by Environmental Factors

Genome Wide Association Studies (Gwas) And Their Clinical Applications In Asthma

Lung Eqtls to Help Reveal the Molecular Underpinnings of Asthma.

Integrative genetic and metabolite profiling analysis suggests altered phosphatidylcholine metabolism in asthma.

Genetic liability to asthma and risk of cardiovascular diseases: A Mendelian randomization study

Integrated genomics analysis highlights important SNPs and genes implicated in moderate-to-severe asthma based on GWAS and eQTL datasets

Unspecified asthma, childhood-onset, and adult-onset asthma have different causal genes: a Mendelian randomization analysis

Present status on the genetic studies of asthma

Advance in Search for Pharmacogenomics of Asthma